Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Abcam Plc (ABC.LN)

Abcam Plc (ABC.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Relation Therapeutics, the Active-Graph Machine Learning Drug Discovery Company, Names David Roblin as CEO and Lindsay Edwards as CTO

Relation Therapeutics, the pioneer of drug discovery using active-graph machine learning (ML) combined with single-cell analysis and deep clinical insights, announced today that it had raised a $25 million...

QGEN : 41.61 (+0.95%)
ABC.LN : 1,226.000 (+11.15%)
TMO : 571.17 (+4.16%)
Abcam Plc Results for the 12- and 18-month periods ended 31 December 2021

Growing demand for Abcam’s portfolio of in-house products drives calendar 2021 revenues up by 22% at constant exchange rates Acquisition of BioVision...

ABC.LN : 1,226.000 (+11.15%)
ABCM : 23.99 (+0.04%)
Abcam Collaborates With Twist Bioscience to Enhance Antibody Discovery for Diagnostic and Research Applications

Twist Bioscience Corporation (NASDAQ:TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Abcam (AIM:ABC; NASDAQ:ABCM), a...

ABCM : 23.99 (+0.04%)
ABC.LN : 1,226.000 (+11.15%)
TWST : 31.79 (+7.95%)

Barchart Exclusives

Bottom 100 Stocks to Buy: Very Aggressive Investors Might Consider a Small Wager on This Class Action Stock
Sonder Holdings faces a potential class action lawsuit over the handling of its financial statements in 2022 and 2023. The penny stock has lost nearly 60% of its value over the past year and is in Barchart’s Bottom 100 Stocks to Buy. Yet, it could be a moneymaker for aggressive investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar